Pfizer, Moderna seek FDA's authorization for second COVID-19 booster shots
STORY: Pfizer, Moderna seek FDA's authorization for second COVID-19 booster shots
DATELINE: March 19, 2022
LENGTH: 00:02:36
LOCATION: Washington D.C.
CATEGORY: HEALTH
SHOTLIST:
1. various of the vaccine production line
STORYLINE:
American biotechnology company Moderna submitted a request to the U.S. Food and Drug Administration (FDA) on Thursday for emergency use authorization (EUA) on a fourth dose of its COVID-19 vaccine for adults 18 years of age and older, who already received a booster dose of any approved or authorized shot.
The request to include adults over 18 years of age was made to provide flexibility for the U.S. Centers for Disease Control and Prevention and healthcare providers to "determine the appropriate use of an additional booster dose," including for those at higher risk of COVID-19 due to age or comorbidities, said the company in a statement.
Currently a booster dose of the Moderna COVID-19 vaccine at the 50 microgram dose level is authorized by the FDA for emergency use in the Unite
- Product Code
- ILEA000943145
- Registered date
- 2022/3/19 00:00:00
- Credit
- Xinhua / Kyodo News Images
- Media source
- Xinhua News Agency.All Rights Reserved
- Media size
- 1920 × 1080 pixel
- Deployment size
- 152.27(MB)*
*File size when opened in Photoshop, etc.